Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.

about

Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy.Metabotropic Glutamate Receptor 5 in the Medial Prefrontal Cortex as a Molecular Determinant of Pain and Ensuing Depression

P2860

Q52600080-F5D6789A-76DB-41F0-8E64-F396C5A1390A Q57817547-05C71B86-9154-41A9-9281-A1E06A92EA61

P2860

Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.

Item

http://www.wikidata.org/entity/Q47383203

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metabotropic Glutamatergic Rec ...... From Receptor Imaging Studies.

@en

Metabotropic Glutamatergic Rec ...... From Receptor Imaging Studies.

@nl

type

Item

label

Metabotropic Glutamatergic Rec ...... From Receptor Imaging Studies.

@en

Metabotropic Glutamatergic Rec ...... From Receptor Imaging Studies.

@nl

prefLabel

Metabotropic Glutamatergic Rec ...... From Receptor Imaging Studies.

@en

Metabotropic Glutamatergic Rec ...... From Receptor Imaging Studies.

@nl

P1476

Metabotropic Glutamatergic Rec ...... From Receptor Imaging Studies

@en

P2093

Irina Esterlis

http://www.w3.org/2001/XMLSchema#string

John H Krystal

http://www.w3.org/2001/XMLSchema#string

Sophie E Holmes

http://www.w3.org/2001/XMLSchema#string

P2860

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders

Ketamine for treatment-resistant unipolar depression: current evidence

Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus

Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity

The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine

Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges

P304

95-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2017.08.025

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christine Delorenzo

Priya Sharma

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29100629

http://www.w3.org/2001/XMLSchema#string

P932

5858955

http://www.w3.org/2001/XMLSchema#string

Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.

about

P2860

P2860

Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932